Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), today announced a Medical Device Correction for the Omnipod® 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable. This does not impact the Omnipod 5 Pod, the Omnipod® DASH Insulin MLink to original article HITAC Recommendations on ONC Adopted Standards Addressing Evolving Health Information Technology Needs in Pediatric Care: Neonatal Abstinence Syndrome (NAS) Informational Resource (IR) Share Print Please login or register to post comments.